University of Wisconsin, Madison

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).

1,039 total trials 151 currently recruiting 712 completed early-phase tilt top decile by trial count

University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.

University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.

Top-decile sponsor footprint

University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 56/100

712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,039 total, page 10 of 21

COMPLETED

Adaption of Mobilizing Older Adult Patients Via a Systems-based Intervention for a Non-Academic Hospital

NCT03887572

COMPLETED NA

Oscillatory Contributions to Working Memory and Attention

NCT03787134

COMPLETED NA

Laser Hair Removal for Treatment of Pilonidal Disease

NCT03949140

COMPLETED Phase 4

The OBstetric Lidocaine Patch (OBLido) Trial

NCT03810235

COMPLETED NA

Promotion of Well-being of Young Adult Brain Cancer Survivors

NCT03871686

COMPLETED

Nasal Swab Home Collection Kit (NSHC Kit) Study

NCT03813966

COMPLETED Phase 3

Immunonutrition and Carbohydrate Loading Strategies in Breast Reconstruction

NCT03764943

COMPLETED

Use of High-resolution Manometry to Detect Upper Airway Obstruction During Sleep

NCT04139499

COMPLETED NA

Using Partners to Enhance Long-Term Weight Loss

NCT03801174

COMPLETED Phase 2

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

NCT03703492

COMPLETED

Outcomes of Septic Shock Patients Treated With a Metabolic Resuscitation Bundle Consisting of Intravenous Hydrocortisone, Ascorbic Acid and Thiamine.

NCT03913468

TERMINATED Phase 2

Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies

NCT03387514

COMPLETED NA

Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors

NCT03722030

COMPLETED NA

Self-efficacy, Beliefs and Adherence- Pilot and Feasibility Trial of a Pharmacist-led Intervention

NCT03406923

COMPLETED

Use of Lung Ultrasound to Diagnose the Etiology of Respiratory Failure in a PICU.

NCT03744169

COMPLETED NA

Cerebrovascular Response to Acute Exercise

NCT03722953

COMPLETED Phase 2

The Synapse Project

NCT04871074

TERMINATED Phase 2

ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer

NCT03733119

COMPLETED Phase 2

Improving Right Ventricular Function in Young Adults Born Preterm

NCT03696758

TERMINATED NA

Paravertebral Versus Pectoralis Block for Post Mastectomy Pain

NCT03656679

COMPLETED NA

Teachers and Parents as Partners During Middle School RCT

NCT03614026

COMPLETED NA

The Utility of Urinalysis Prior to In-Office Procedures

NCT03526484

COMPLETED NA

Stroke Rehabilitation Using Brain-Computer Interface (BCI) Technology

NCT04141774

COMPLETED Early Phase 1

Impact of Probiotics on Oral Microbiota in Older Adults With Dysphagia

NCT03682094

TERMINATED NA

External Ventricular Drain Placement Stealth Study

NCT03696043

COMPLETED NA

Proposing Forgiveness Therapy Within Prison

NCT04373954

TERMINATED Phase 1

Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma

NCT02782715

COMPLETED NA

Air-Q® SP Versus Williams Intubating Airway for Single-Operator FOI

NCT03247803

COMPLETED Phase 4

Improving Quitline Support Study

NCT03538938

COMPLETED NA

Facilitated Implementation of Antibiotic Stewardship in Wisconsin Nursing Homes

NCT03520010

COMPLETED Phase 1

Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer

NCT03490292

COMPLETED Phase 2

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

NCT03462459

COMPLETED

Technical Validation of MR Biomarkers of Obesity-Associated NAFLD

NCT03674528

COMPLETED

PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients

NCT03342378

COMPLETED

NIRS Monitoring to Detect AKI in Preterm Infants

NCT03384173

COMPLETED NA

ConsCIOUS2 Study of the Isolated Forearm Technique Commands

NCT03503357

COMPLETED NA

A "Stand Up and Move More" Intervention for Older Adults

NCT03412084

COMPLETED NA

Impact of Mindfulness Training on Stress-related Health Outcomes in Law Enforcement

NCT03488875

TERMINATED Phase 1

Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition

NCT03275597

TERMINATED

Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy

NCT03393741

COMPLETED NA

Impact of Mobile App on Purpose and Well-Being Among College Students

NCT03378505

COMPLETED Early Phase 1

Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer

NCT03358563

COMPLETED

Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster

NCT03553472

COMPLETED NA

Multiple Chronic Conditions for Older Adults

NCT03387735

COMPLETED

Organizational Change in Dental Care

NCT03367416

COMPLETED

Children's Respiratory and Environmental Workgroup

NCT03213184

COMPLETED Phase 2

FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer

NCT03212170

COMPLETED NA

Endocannabinoid and Psychological Responses to Yoga in Healthy Adults

NCT03710577

COMPLETED NA

Psychotherapy Trial With Transgender Clients

NCT03369054

TERMINATED Phase 4

Deep Brain Stimulation (DBS) Sedation

NCT03283150

← Previous Page 10 of 21 Next →

Phase Distribution

PhaseTrial count
Phase 1 109
Phase 2 142
Phase 3 19
Phase 4 79

What is open in the University of Wisconsin, Madison pipeline

151 recruiting of 1,039 indexed (15% open); 712 completed (69%).

Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).

Top condition: Healthy (10 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Wisconsin, Madison: open-pipeline peers nationwide

Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 6%8%10%12%14%16% Total trials Recruiting share University of Wisconsin, MadisonUniversity of WashingtonBristol-Myers SquibbUniversity of FloridaUniversity of North Carolina, Chapel HillMasonic Cancer Center, University of MinnesotaModernaTXUnited States Naval Medical Center, San DiegoThe Cleveland Clinic
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,039 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this University of Wisconsin, Madison page

1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.

  • 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.